6/20/2008 - DBM Receives Second Round of Funding, Converts to C Corp.

Pursuant to meeting milestones set at its launch in late 2007, DiscoveryBioMed closed on a second round of funding from the Birmingham Technology Fund.  “With this additional investment, we will take DBM to the next level with regard to its services and R&D work, as scripted within our business plan," said CEO Erik Schwiebert.  The advice and mentorship of Larry Greer, Alan Dean, and the principals of Greer Capital Advisors continue to be invaluable.  Simultaneously with this round of funding, DBM converted from a LLC to C-corporation to better reflect its investment profile and growth strategy.

<-- Go Back